|
|
Volumn 33, Issue 7-8, 2001, Pages 3688-3690
|
|
Prospective analysis and successful treatment of thrombotic microangiopathy in renal allografts under tacrolimus immunosuppression
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
LACTATE DEHYDROGENASE;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
ARTICLE;
BLOOD GROUP ABO SYSTEM;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
ERYTHROCYTE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HEMATOCRIT;
HUMAN;
HUMAN TISSUE;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY ALLOGRAFT;
KIDNEY BIOPSY;
KIDNEY FUNCTION;
MAJOR CLINICAL STUDY;
PATHOPHYSIOLOGY;
PLASMA;
PLASMAPHERESIS;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RISK FACTOR;
THROMBOCYTE COUNT;
THROMBOTIC THROMBOCYTOPENIC PURPURA;
ABO BLOOD-GROUP SYSTEM;
BLOOD GROUP INCOMPATIBILITY;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
PERIPHERAL VASCULAR DISEASES;
PLASMAPHERESIS;
POSTOPERATIVE COMPLICATIONS;
TACROLIMUS;
THROMBOSIS;
TRANSPLANTATION, HOMOLOGOUS;
|
|
EID: 0035676161
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02504-0 Document Type: Article |
|
Times cited : (5)
|
|
References (6)
|
